Bamco Inc. NY Lowers Position in Mettler-Toledo International, Inc. $MTD

Bamco Inc. NY decreased its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 14.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 238,933 shares of the medical instruments supplier’s stock after selling 41,992 shares during the period. Mettler-Toledo International accounts for 0.8% of Bamco Inc. NY’s portfolio, making the stock its 24th largest position. Bamco Inc. NY owned about 1.16% of Mettler-Toledo International worth $280,679,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in MTD. Townsquare Capital LLC raised its position in shares of Mettler-Toledo International by 15.1% in the 1st quarter. Townsquare Capital LLC now owns 740 shares of the medical instruments supplier’s stock worth $874,000 after buying an additional 97 shares during the period. Public Sector Pension Investment Board raised its holdings in shares of Mettler-Toledo International by 7.5% in the 1st quarter. Public Sector Pension Investment Board now owns 2,854 shares of the medical instruments supplier’s stock worth $3,370,000 after purchasing an additional 200 shares during the period. Resona Asset Management Co. Ltd. lifted its stake in shares of Mettler-Toledo International by 4.4% in the 1st quarter. Resona Asset Management Co. Ltd. now owns 6,791 shares of the medical instruments supplier’s stock valued at $8,015,000 after purchasing an additional 285 shares in the last quarter. National Pension Service grew its holdings in shares of Mettler-Toledo International by 11.6% during the 1st quarter. National Pension Service now owns 37,241 shares of the medical instruments supplier’s stock worth $43,978,000 after purchasing an additional 3,873 shares during the period. Finally, Horizon Investments LLC increased its position in Mettler-Toledo International by 4.2% during the 1st quarter. Horizon Investments LLC now owns 299 shares of the medical instruments supplier’s stock worth $353,000 after purchasing an additional 12 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MTD. Stifel Nicolaus lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Barclays upped their price target on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a research report on Monday, November 10th. Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Finally, Citigroup upped their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Five investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $1,424.17.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,394.97 on Friday. The company’s fifty day moving average price is $1,402.13 and its two-hundred day moving average price is $1,292.07. The firm has a market capitalization of $28.50 billion, a P/E ratio of 34.79, a P/E/G ratio of 4.59 and a beta of 1.40. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same period last year, the firm earned $10.21 earnings per share. The company’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Buying and Selling

In related news, CFO Shawn Vadala sold 1,895 shares of the company’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $1,455.52, for a total value of $2,758,210.40. Following the sale, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,696,789.76. This represents a 26.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Gerry Keller sold 236 shares of the stock in a transaction on Friday, November 21st. The shares were sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the transaction, the insider owned 159 shares in the company, valued at $225,554.22. This trade represents a 59.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 19,565 shares of company stock worth $28,683,737 over the last 90 days. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.